{"filing":{"accession_number":"0001087294-26-000055","cik":"0001087294","ticker":"CPIX","company_name":"CUMBERLAND PHARMACEUTICALS INC","form":"8-K","filing_date":"2026-07-13","report_date":null,"primary_document":"cpix-20260713.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000055/cpix-20260713.htm"},"events":[{"id":17675,"run_id":15841,"accession_number":"0001087294-26-000055","anchor_item_number":"8.01","event_type":"dividend_distribution","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"The filing discloses the Board's authorization and declaration of a special cash dividend of $1.50 per share payable on July 31, 2026, to shareholders of record as of July 23, 2026. This is a material return of capital to shareholders. While the filing also mentions a share repurchase program authorization, the primary and most prominent disclosure is the special dividend declaration, which is a direct distribution to all shareholders.","company_name":"CUMBERLAND PHARMACEUTICALS INC","ticker":"CPIX","filing_date":"2026-07-13","form":"8-K","submitted_at":null,"items":[{"id":16237,"accession_number":"0001087294-26-000055","item_number":"8.01","item_title":"Other Events","event_type":"dividend_distribution","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the Board's authorization and declaration of a special cash dividend of $1.50 per share payable on July 31, 2026, to shareholders of record as of July 23, 2026. This is a material return of capital to shareholders. While the filing also mentions a share repurchase program authorization, the primary and most prominent disclosure is the special dividend declaration, which is a direct distribution to all shareholders.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-13T21:28:37.254886+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":16237,"accession_number":"0001087294-26-000055","item_number":"8.01","item_title":"Other Events","event_type":"dividend_distribution","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the Board's authorization and declaration of a special cash dividend of $1.50 per share payable on July 31, 2026, to shareholders of record as of July 23, 2026. This is a material return of capital to shareholders. While the filing also mentions a share repurchase program authorization, the primary and most prominent disclosure is the special dividend declaration, which is a direct distribution to all shareholders.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-13T21:28:37.254886+00:00","company_name":"CUMBERLAND PHARMACEUTICALS INC","ticker":"CPIX","filing_date":"2026-07-13"}]}